Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Isoglutamine

Home DrugsIsoglutamine

Experimental

Small Molecule

Isoglutamine

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₅H₁₀N₂O₃
CAS Number: 636-65-7
UNII ID: WL74QNU57B

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Method for synthesizing D-isoglutamine-D-tryptophan
Applicant: CHINESE PEPTIDE COMPANYPriority: 2016
CN
Cell wall acyl-alanyl-D-isoglutamine derivative and its prepn, medicine composition and use
Applicant: INST OF MEDICAMENT CHINESE ACAPriority: 2003
CN
Dietary and pharmaceutical compositions for treatment of anemia, thrombocytopenia, and leukopenia
Applicant: PINEGRIN BORIS VPriority: 2003
US
Method for finding novel peptide immunostimulatory adjuvants, compositions and methods of use
Applicant: BROVKO FEDOR ALEXANDROVICHPriority: 2008
US
Phenylacetic acid compositions for treating or preventing hypercholesterolemia
Applicant: BURZYNSKI STANISLAW RPriority: 2000
US
Monoclonal antibody against muramyl peptides
Applicant: AGENCY SCIENCE TECH & RESPriority: 2012
US
2 publications
Glycopeptides for the treatment of als and other metabolic and autoimmune disorders
Applicant: RAJADHYAKSHA V JPriority: 2004
US
Structural modification method of muramyl dipeptide and application of muramyl dipeptide in delivery of lipid nanoparticles and nucleic acid drugs
Applicant: UNIV CHINA PHARMAPriority: 2023
CN